Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 11—November 2004
Research

Enhanced Identification of Postoperative Infections among Inpatients

Deborah S. Yokoe*Comments to Author , Gary A. Noskin†, Susan M. Cunningham†, Gianna Zuccotti‡, Theresa Plaskett‡, Victoria J. Fraser§, Margaret A. Olsen§, Jerome I. Tokars¶, Steven Solomon¶, Trish M. Perl#, Sara E. Cosgrove#, Richard S. Tilson*, Maurice Greenbaum**, David C. Hooper††, Kenneth E. Sands‡‡, John Tully§§, Loreen A. Herwaldt¶¶, Daniel J. Diekema¶¶, Edward S. Wong##, Michael Climo##, and Richard Platt***
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Northwestern University, Chicago, Illinois, USA; ‡Memorial Sloan-Kettering Cancer Center, New York, New York, USA; §Washington University School of Medicine, St. Louis, Missouri, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; **North Shore Medical Center-Salem Hospital, Salem, Massachusetts, USA; ††Massachusetts General Hospital, Boston, Massachusetts, USA; ‡‡Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; §§Mount Auburn Medical Center, Cambridge, Massachusetts, USA; ¶¶University of Iowa Carver College of Medicine, Iowa City, Iowa, USA; ##McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA; ***Harvard Pilgrim Health Care, Boston, Massachusetts, USA

Main Article

Table 2

SSI rates after CABG procedures, cesarean delivery, and breast proceduresa,b

Procedure/phase SSI rates detected by
% routine surveillance
(SSI/ procedures) [95% CI] Any method %c
(SSI/procedures) [95% CI]
CABG
Phase 1 4.9 (112/2,267)
[4.1%–5.9%] 6.3 (142/2,267)
[5.3%–7.3%]
Phase 2 4.6 (298/6,472)
[4.1%–5.1%] 7.7 (501/6,472)
[7.1%–8.9%]
Combined 4.7 (410/8,739) 7.4 (643/8,739)
Cesarean delivery
Phase 1 1.6 (43/2,659)
[1.2%–2.2%] 4.1 (110/2,659)
[3.4%–5.0%]
Phase 2 1.6 (49/3,065)d
[1.2%–2.1%] 5.5 (263/4,740)
[4.8%–6.3%]
Combined 1.6 (92/5,724) 5.0 (373/7,399)
Breast procedures
Phase 1 0.7 (10/1,477)
[0.3%–1.2%] 0.9 (14/1,477)
[0.5%–1.6%]
Phase 2 0.4 (7/1,765)d
[0.2%–0.8%] 2.3 (110/4,698)
[2.1%–2.8%]
Combined 0.5 (17/3,242) 2.0 (124/6,175)

aBased on routine surveillance and routine surveillance plus screening for antimicrobial drug exposure, discharge diagnosis codes, or both.
bSSI, surgical site infection; CABG, coronary artery bypass graft; CI, confidence interval.
cRoutine, antimicrobial exposure, diagnosis codes.
dThe total number of procedures is noted for the hospitals that had performed routine surveillance.

Main Article

Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external